Literature DB >> 23678168

Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Hironori Nishitsuji1, Kenji Funami, Yuko Shimizu, Saneyuki Ujino, Kazuo Sugiyama, Tsukasa Seya, Hiroshi Takaku, Kunitada Shimotohno.   

Abstract

Inflammatory cytokines and chemokines play important roles in inflammation during viral infection. Hepatitis C virus (HCV) is a hepatotropic RNA virus that is closely associated with chronic liver inflammation, fibrosis, and hepatocellular carcinoma. During the progression of HCV-related diseases, hepatic stellate cells (HSCs) contribute to the inflammatory response triggered by HCV infection. However, the underlying molecular mechanisms that mediate HSC-induced chronic inflammation during HCV infection are not fully understood. By coculturing HSCs with HCV-infected hepatocytes in vitro, we found that HSCs stimulated HCV-infected hepatocytes, leading to the expression of proinflammatory cytokines and chemokines such as interleukin-6 (IL-6), IL-8, macrophage inflammatory protein 1α (MIP-1α), and MIP-1β. Moreover, we found that this effect was mediated by IL-1α, which was secreted by HSCs. HCV infection enhanced production of CCAAT/enhancer binding protein (C/EBP) β mRNA, and HSC-dependent IL-1α production contributed to the stimulation of C/EBPβ target cytokines and chemokines in HCV-infected hepatocytes. Consistent with this result, knockdown of mRNA for C/EBPβ in HCV-infected hepatocytes resulted in decreased production of cytokines and chemokines after the addition of HSC conditioned medium. Induction of cytokines and chemokines in hepatocytes by the HSC conditioned medium required a yet to be identified postentry event during productive HCV infection. The cross talk between HSCs and HCV-infected hepatocytes is a key feature of inflammation-mediated, HCV-related diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23678168      PMCID: PMC3700210          DOI: 10.1128/JVI.00974-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.

Authors:  Songyun Zhu; Kyungsil Yoon; Esta Sterneck; Peter F Johnson; Robert C Smart
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.

Authors:  P L Shields; C M Morland; M Salmon; S Qin; S G Hubscher; D H Adams
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

Review 3.  Kupffer cells: their activation and role in animal models of liver injury and human liver disease.

Authors:  P J Winwood; M J Arthur
Journal:  Semin Liver Dis       Date:  1993-02       Impact factor: 6.115

4.  The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection.

Authors:  Anthony J Freeman; Yong Pan; Charles E Harvey; Jeffrey J Post; Matthew G Law; Peter A White; William D Rawlinson; Andrew R Lloyd; George Marinos; Rosemary A Ffrench
Journal:  J Hepatol       Date:  2003-03       Impact factor: 25.083

5.  Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target.

Authors:  Soazig Le Lay; Isabelle Lefrère; Christian Trautwein; Isabelle Dugail; Stéphane Krief
Journal:  J Biol Chem       Date:  2002-06-04       Impact factor: 5.157

6.  Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients.

Authors:  Aldona Kasprzak; Maciej Zabel; Wiesława Biczysko; Jacek Wysocki; Agnieszka Adamek; Rafał Spachacz; Joanna Surdyk-Zasada
Journal:  J Histochem Cytochem       Date:  2004-01       Impact factor: 2.479

7.  Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

Authors:  Charles E Harvey; Jeffrey J Post; Patricia Palladinetti; Anthony J Freeman; Rosemary A Ffrench; Rakesh K Kumar; George Marinos; Andrew R Lloyd
Journal:  J Leukoc Biol       Date:  2003-09       Impact factor: 4.962

Review 8.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

9.  Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta.

Authors:  M Wegner; Z Cao; M G Rosenfeld
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

10.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  32 in total

Review 1.  Regulation of hepatic innate immunity by hepatitis C virus.

Authors:  Stacy M Horner; Michael Gale
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 2.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

Review 3.  Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.

Authors:  Ralf Weiskirchen; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

4.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

5.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

6.  Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.

Authors:  Albert Do; Denise A Esserman; Supriya Krishnan; Joseph K Lim; Tamar H Taddei; Ronald G Hauser; Janet P Tate; Vincent Lo Re; Amy C Justice
Journal:  J Gen Intern Med       Date:  2020-04-27       Impact factor: 5.128

7.  Immunological changes in different patient populations with chronic hepatitis C virus infection.

Authors:  Laszlo Szereday; Matyas Meggyes; Melinda Halasz; Julia Szekeres-Bartho; Alajos Par; Gabriella Par
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

8.  Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.

Authors:  Stephen Correia; Ronald Cohen; Assawin Gongvatana; Skye Ross; James Olchowski; Kathryn Devlin; Karen Tashima; Bradford Navia; Suzanne Delamonte
Journal:  J Neuroimmunol       Date:  2013-09-27       Impact factor: 3.478

9.  Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.

Authors:  Nayan J Sarma; Venkataswarup Tiriveedhi; Jeffrey S Crippin; William C Chapman; Thalachallour Mohanakumar
Journal:  J Virol       Date:  2014-01-15       Impact factor: 5.103

Review 10.  Beyond Metabolism: Role of the Immune System in Hepatic Toxicity.

Authors:  Kenneth L Hastings; Martin D Green; Bin Gao; Patricia E Ganey; Robert A Roth; Gary R Burleson
Journal:  Int J Toxicol       Date:  2020 Mar/Apr       Impact factor: 2.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.